These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32279122)

  • 1. Astrocytic IGFBP2 and CHI3L1 in cerebrospinal fluid drive cortical metastasis of HER2+breast cancer.
    Ansari KI; Bhan A; Liu X; Chen MY; Jandial R
    Clin Exp Metastasis; 2020 Jun; 37(3):401-412. PubMed ID: 32279122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of neurotrophin receptor TrkB and Her2 in breast cancer cells facilitates brain metastases.
    Choy C; Ansari KI; Neman J; Hsu S; Duenas MJ; Li H; Vaidehi N; Jandial R
    Breast Cancer Res; 2017 Apr; 19(1):51. PubMed ID: 28446206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocyte-induced Reelin expression drives proliferation of Her2
    Jandial R; Choy C; Levy DM; Chen MY; Ansari KI
    Clin Exp Metastasis; 2017 Feb; 34(2):185-196. PubMed ID: 28210910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism.
    Sartorius CA; Hanna CT; Gril B; Cruz H; Serkova NJ; Huber KM; Kabos P; Schedin TB; Borges VF; Steeg PS; Cittelly DM
    Oncogene; 2016 Jun; 35(22):2881-92. PubMed ID: 26411365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive growth of brain metastases is linked to CHI3L1 release from pSTAT3-positive astrocytes.
    Dankner M; Maritan SM; Priego N; Kruck G; Nkili-Meyong A; Nadaf J; Zhuang R; Annis MG; Zuo D; Nowakowski A; Biondini M; Kiepas A; Mourcos C; Le P; Charron F; Inglebert Y; Savage P; Théret L; Guiot MC; McKinney RA; Muller WJ; Park M; Valiente M; Petrecca K; Siegel PM
    Neuro Oncol; 2024 Jun; 26(6):1052-1066. PubMed ID: 38271182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of MIIP regulates human breast cancer proliferation, invasion and migration by mediated by IGFBP2.
    Du Y; Wang P
    Pathol Res Pract; 2019 Jul; 215(7):152440. PubMed ID: 31078343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells.
    Sierra A; Price JE; García-Ramirez M; Méndez O; López L; Fabra A
    Lab Invest; 1997 Oct; 77(4):357-68. PubMed ID: 9354770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric Inhibition of HER2 by Moesin-Mimicking Compounds Targets HER2-Positive Cancers and Brain Metastases.
    Faure C; Djerbi-Bouillié R; Domingot A; Bouzinba-Segard H; Taouji S; Saidi Y; Bernard S; Carallis F; Rothe-Walther R; Lenormand JL; Chevet E; Bourdoulous S
    Cancer Res; 2021 Nov; 81(21):5464-5476. PubMed ID: 34493594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases.
    Kanojia D; Balyasnikova IV; Morshed RA; Frank RT; Yu D; Zhang L; Spencer DA; Kim JW; Han Y; Yu D; Ahmed AU; Aboody KS; Lesniak MS
    Stem Cells; 2015 Oct; 33(10):2985-94. PubMed ID: 26260958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 drives metastatic breast cells from brain lesions into the cerebrospinal fluid and systemic circulation.
    Allen JE; Patel AS; Prabhu VV; Dicker DT; Sheehan JM; Glantz MJ; El-Deiry WS
    Cancer Res; 2014 May; 74(9):2385-90. PubMed ID: 24614081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies.
    Goyette MA; Stevens LE; DePinho CR; Seehawer M; Nishida J; Li Z; Wilde CM; Li R; Qiu X; Pyke AL; Zhao S; Lim K; Tender GS; Northey JJ; Riley NM; Long HW; Bertozzi CR; Weaver VM; Polyak K
    Proc Natl Acad Sci U S A; 2024 May; 121(20):e2322688121. PubMed ID: 38709925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine GMCSF Signaling Contributes to Growth of HER2
    Ansari KI; Bhan A; Saotome M; Tyagi A; De Kumar B; Chen C; Takaku M; Jandial R
    Cancer Res; 2021 Sep; 81(18):4723-4735. PubMed ID: 34247146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
    Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL
    Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGFBP2 promotes salivary adenoid cystic carcinoma metastasis by activating the NF-κB/ZEB1 signaling pathway.
    Yao X; Wang Y; Duan Y; Zhang Q; Li P; Jin R; Tao Y; Zhang W; Wang X; Jing C; Zhou X
    Cancer Lett; 2018 Sep; 432():38-46. PubMed ID: 29885520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bruton's Tyrosine Kinase Inhibitors Prevent Therapeutic Escape in Breast Cancer Cells.
    Wang X; Wong J; Sevinsky CJ; Kokabee L; Khan F; Sun Y; Conklin DS
    Mol Cancer Ther; 2016 Sep; 15(9):2198-208. PubMed ID: 27256378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2
    Nagpal A; Redvers RP; Ling X; Ayton S; Fuentes M; Tavancheh E; Diala I; Lalani A; Loi S; David S; Anderson RL; Smith Y; Merino D; Denoyer D; Pouliot N
    Breast Cancer Res; 2019 Aug; 21(1):94. PubMed ID: 31409375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis.
    Cordero A; Kanojia D; Miska J; Panek WK; Xiao A; Han Y; Bonamici N; Zhou W; Xiao T; Wu M; Ahmed AU; Lesniak MS
    Oncogene; 2019 Sep; 38(37):6445-6460. PubMed ID: 31324889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2
    Priceman SJ; Tilakawardane D; Jeang B; Aguilar B; Murad JP; Park AK; Chang WC; Ostberg JR; Neman J; Jandial R; Portnow J; Forman SJ; Brown CE
    Clin Cancer Res; 2018 Jan; 24(1):95-105. PubMed ID: 29061641
    [No Abstract]   [Full Text] [Related]  

  • 19. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
    Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
    Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers.
    Baldassarre T; Truesdell P; Craig AW
    Breast Cancer Res; 2017 Oct; 19(1):110. PubMed ID: 28974266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.